BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 34921134)

  • 21. Sirtuin 6 inhibits colon cancer progression by modulating PTEN/AKT signaling.
    Tian J; Yuan L
    Biomed Pharmacother; 2018 Oct; 106():109-116. PubMed ID: 29957460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Knockdown of ZNF479 inhibits proliferation and glycolysis of gastric cancer cells through regulating β-catenin/c-Myc signaling pathway.
    Jin XS; Ji TT; Shi ZC; Zhang QQ; Ye FP; Yu WL; Li RZ
    Kaohsiung J Med Sci; 2021 Sep; 37(9):759-767. PubMed ID: 34042257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of glucose uptake in lymphoma cell lines by c-MYC- and PI3K-dependent signaling pathways and impact of glycolytic pathways on cell viability.
    Broecker-Preuss M; Becher-Boveleth N; Bockisch A; Dührsen U; Müller S
    J Transl Med; 2017 Jul; 15(1):158. PubMed ID: 28724379
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HSulf-1 deficiency dictates a metabolic reprograming of glycolysis and TCA cycle in ovarian cancer.
    Mondal S; Roy D; Camacho-Pereira J; Khurana A; Chini E; Yang L; Baddour J; Stilles K; Padmabandu S; Leung S; Kalloger S; Gilks B; Lowe V; Dierks T; Hammond E; Dredge K; Nagrath D; Shridhar V
    Oncotarget; 2015 Oct; 6(32):33705-19. PubMed ID: 26378042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Far upstream element -binding protein 1 (FUBP1) participates in the malignant process and glycolysis of colon cancer cells by combining with c-Myc.
    Wang S; Wang Y; Li S; Nian S; Xu W; Liang F
    Bioengineered; 2022 May; 13(5):12115-12126. PubMed ID: 35546072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HMGA1 promoting gastric cancer oncogenic and glycolytic phenotypes by regulating c-myc expression.
    Cao XP; Cao Y; Zhao H; Yin J; Hou P
    Biochem Biophys Res Commun; 2019 Aug; 516(2):457-465. PubMed ID: 31229266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppression of c-Myc is involved in multi-walled carbon nanotubes' down-regulation of ATP-binding cassette transporters in human colon adenocarcinoma cells.
    Wang Z; Xu Y; Meng X; Watari F; Liu H; Chen X
    Toxicol Appl Pharmacol; 2015 Jan; 282(1):42-51. PubMed ID: 25461681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Osteopontin knockdown suppresses the growth and angiogenesis of colon cancer cells.
    Wu XL; Lin KJ; Bai AP; Wang WX; Meng XK; Su XL; Hou MX; Dong PD; Zhang JJ; Wang ZY; Shi L
    World J Gastroenterol; 2014 Aug; 20(30):10440-8. PubMed ID: 25132760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CDX2 inhibits the proliferation and tumor formation of colon cancer cells by suppressing Wnt/β-catenin signaling via transactivation of GSK-3β and Axin2 expression.
    Yu J; Liu D; Sun X; Yang K; Yao J; Cheng C; Wang C; Zheng J
    Cell Death Dis; 2019 Jan; 10(1):26. PubMed ID: 30631044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A miR-567-PIK3AP1-PI3K/AKT-c-Myc feedback loop regulates tumour growth and chemoresistance in gastric cancer.
    Zhang F; Li K; Yao X; Wang H; Li W; Wu J; Li M; Zhou R; Xu L; Zhao L
    EBioMedicine; 2019 Jun; 44():311-321. PubMed ID: 31078520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. circCTIC1 promotes the self-renewal of colon TICs through BPTF-dependent c-Myc expression.
    Zhan W; Liao X; Wang Y; Li L; Li J; Chen Z; Tian T; He J
    Carcinogenesis; 2019 Jun; 40(4):560-568. PubMed ID: 30403769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SPAG5 upregulation contributes to enhanced c-MYC transcriptional activity via interaction with c-MYC binding protein in triple-negative breast cancer.
    Li M; Li A; Zhou S; Lv H; Yang W
    J Hematol Oncol; 2019 Feb; 12(1):14. PubMed ID: 30736840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ectopic expression of miR-494 inhibited the proliferation, invasion and chemoresistance of pancreatic cancer by regulating SIRT1 and c-Myc.
    Liu Y; Li X; Zhu S; Zhang JG; Yang M; Qin Q; Deng SC; Wang B; Tian K; Liu L; Niu Y; Wang CY; Zhao G
    Gene Ther; 2015 Sep; 22(9):729-38. PubMed ID: 25965392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Morin and Esculetin supplementation modulates c-myc induced energy metabolism and attenuates neoplastic changes in rats challenged with the procarcinogen 1,2 - dimethylhydrazine.
    Sharma SH; Thulasingam S; Chellappan DR; Chinnaswamy P; Nagarajan S
    Eur J Pharmacol; 2017 Feb; 796():20-31. PubMed ID: 27989504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Downregulation of circDYNC1H1 exhibits inhibitor effect on cell proliferation and migration in hepatocellular carcinoma through miR-140-5p.
    Wang ZY; Zhu Z; Wang HF; Qin B; Liu J; Yao XH; Li WC; Chen KS
    J Cell Physiol; 2019 Aug; 234(10):17775-17785. PubMed ID: 30864145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glycolysis is essential for chemoresistance induced by transient receptor potential channel C5 in colorectal cancer.
    Wang T; Ning K; Sun X; Zhang C; Jin LF; Hua D
    BMC Cancer; 2018 Feb; 18(1):207. PubMed ID: 29463225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A noncoding RNA LINC00504 interacts with c-Myc to regulate tumor metabolism in colon cancer.
    Feng J; Ma J; Liu S; Wang J; Chen Y
    J Cell Biochem; 2019 Sep; 120(9):14725-14734. PubMed ID: 30998289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of LEF1 by MYC activates the WNT pathway and maintains cell proliferation.
    Hao YH; Lafita-Navarro MC; Zacharias L; Borenstein-Auerbach N; Kim M; Barnes S; Kim J; Shay J; DeBerardinis RJ; Conacci-Sorrell M
    Cell Commun Signal; 2019 Oct; 17(1):129. PubMed ID: 31623618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oxidized LDL receptor 1 (OLR1) as a possible link between obesity, dyslipidemia and cancer.
    Khaidakov M; Mitra S; Kang BY; Wang X; Kadlubar S; Novelli G; Raj V; Winters M; Carter WC; Mehta JL
    PLoS One; 2011; 6(5):e20277. PubMed ID: 21637860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Momordin Ic induces G0/1 phase arrest and apoptosis in colon cancer cells by suppressing SENP1/c-MYC signaling pathway.
    Xianjun F; Xirui X; Jie T; Huiwen M; Shaojun Z; Qiaoyun L; Yunxin L; Xuqun S
    J Pharmacol Sci; 2021 Aug; 146(4):249-258. PubMed ID: 34049792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.